Risk factors for Clostridium difficile toxin-positive diarrhea: a population-based prospective case-control study.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Bjornsson, E S
MetadataShow full item record
CitationEur. J. Clin. Microbiol. Infect. Dis. 2012, 31(10):2601-10
AbstractIncreased incidence and severity of Clostridium difficile infections (CDIs) is of major concern. However, by minimizing known risk factors, the incidence can be decreased. The aim of this investigation was to calculate the incidence and assess risk factors for CDI in our population. A 1-year prospective population-based nationwide study in Iceland of CDIs was carried out. For risk factor evaluation, each case was matched with two age- and sex-matched controls that tested negative for C. difficile toxin. A total of 128 CDIs were identified. The crude incidence was 54 cases annually per 100,000 population >18 years of age. Incidence increased exponentially with older age (319 per 100,000 population >86 years of age). Community-acquired origin was 27 %. Independent risk factors included: dicloxacillin (odds ratio [OR]: 7.55, 95 % confidence interval [CI]: 1.89-30.1), clindamycin (OR: 6.09, 95 % CI: 2.23-16.61), ceftriaxone (OR: 4.28, 95 % CI: 1.59-11.49), living in a retirement home (OR: 3.9, 95 % CI: 1.69-9.16), recent hospital stay (OR: 2.3, 95 % CI: 1.37-3.87). Proton pump inhibitors (PPIs) were used by 60/111 (54 %) versus 91/222 (41 %) (p = 0.026) and ciprofloxacin 19/111 (17 %) versus 19/222 (9 %) (p = 0.027) for cases and controls, respectively. In all, 75 % of primary CDIs treated with metronidazole recovered from one course of treatment. CDI was mostly found among elderly patients. The most commonly identified risk factors were broad-spectrum antibiotics and recent contact with health care institutions. PPI use was significantly more prevalent among CDI patients.
DescriptionTo access publisher's full text version of this article. Please click on the hyperlink in Additional Links field.
RightsArchived with thanks to European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
- Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor.
- Authors: Gordon D, Young LR, Reddy S, Bergman C, Young JD
- Issue date: 2016 Feb
- Enhanced surveillance of Clostridium difficile infection occurring outside hospital, England, 2011 to 2013.
- Authors: Fawley WN, Davies KA, Morris T, Parnell P, Howe R, Wilcox MH, Clostridium difficile Ribotyping Network (CDRN) Working Group.
- Issue date: 2016 Jul 21
- The evaluation of Clostridium difficile infection (CDI) in a community hospital.
- Authors: Daniel A, Rapose A
- Issue date: 2015 Mar-Apr
- Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe.
- Authors: Kurti Z, Lovasz BD, Mandel MD, Csima Z, Golovics PA, Csako BD, Mohas A, Gönczi L, Gecse KB, Kiss LS, Szathmari M, Lakatos PL
- Issue date: 2015 Jun 7
- Clostridium difficile infection in children hospitalized due to diarrhea.
- Authors: Dulęba K, Pawłowska M, Wietlicka-Piszcz M
- Issue date: 2014 Feb